Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Chromadex Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CDXC
Nasdaq
8731
https://chromadex.com/default.aspx
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Chromadex Corp
ChromaDex Corp (CDXC) Q1 2024 Earnings: Aligns with EPS Projections, Misses Revenue Estimates
- May 10th, 2024 7:22 pm
ChromaDex Corporation (NASDAQ:CDXC) Q1 2024 Earnings Call Transcript
- May 9th, 2024 6:34 pm
Q1 2024 Chromadex Corp Earnings Call
- May 9th, 2024 11:17 am
ChromaDex Corp (CDXC) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...
- May 9th, 2024 7:42 am
ChromaDex Corporation Reports First Quarter 2024 Financial Results
- May 8th, 2024 8:04 pm
An Intrinsic Calculation For ChromaDex Corporation (NASDAQ:CDXC) Suggests It's 43% Undervalued
- May 6th, 2024 11:57 am
ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement
- Apr 30th, 2024 12:32 pm
ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®
- Apr 25th, 2024 12:34 pm
ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
- Apr 24th, 2024 12:34 pm
ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market
- Apr 23rd, 2024 12:32 pm
Should You Think About Buying ChromaDex Corporation (NASDAQ:CDXC) Now?
- Apr 5th, 2024 11:43 am
Precision BioSciences (DTIL) Soars 13.4%: Is Further Upside Left in the Stock?
- Apr 2nd, 2024 10:48 am
ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program
- Mar 26th, 2024 12:32 pm
ChromaDex Full Year 2023 Earnings: EPS Beats Expectations
- Mar 8th, 2024 10:16 am
ChromaDex Corp (CDXC) Reports Encouraging Fiscal Year 2023 Results with Positive Adjusted EBITDA
- Mar 7th, 2024 6:59 pm
ChromaDex Corporation (NASDAQ:CDXC) Q4 2023 Earnings Call Transcript
- Mar 7th, 2024 3:37 pm
Q4 2023 Chromadex Corp Earnings Call
- Mar 7th, 2024 11:27 am
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results
- Mar 6th, 2024 9:04 pm
Insiders own 26% of ChromaDex Corporation (NASDAQ:CDXC) shares but retail investors control 44% of the company
- Mar 2nd, 2024 2:00 pm
ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024
- Feb 21st, 2024 1:32 pm
Scroll